metricas
covid
Annals of Hepatology Economic evaluation of non-invasive test pathways for high-risk metabolic dysfun...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
Zobair M. Younossia,b,
Corresponding author
Zobair.Younossi@cldq.org

Corresponding author.
, James M. Paika,b, Linda Henrya,b, Richard F. Pollockc, Maria Stepanovaa,b,d, Fatema Nadera,b,d
a The Global NASH Council, Washington DC, USA
b Beatty Liver and Obesity Research, Inova Health System, Falls Church, VA, USA
c Covalence Research Ltd, Harpenden, UK
d Center for Outcomes Research in Liver Diseases, Washington DC, USA
Read
1710
Times
was read the article
557
Total PDF
1153
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 50 26 76
2025 11 211 172 383
2025 10 92 115 207
2025 9 105 82 187
2025 8 83 59 142
2025 7 108 25 133
2025 6 91 18 109
2025 5 123 11 134
2025 4 76 7 83
2025 3 100 20 120
2025 2 114 22 136

Follow this link to access the full text of the article